Clozapine REMS A Barrier To Treatment And Unnecessary For Safe Use, US FDA Adcomms Say

 
• By Sue Sutter
  
Many open public hearing speakers at the advisory committee meeting wore t-shirts attesting to clozapine's safety. (Sue Sutter)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US Advisory Committees

More from Drug Safety